REVA Medical Reports Third Quarter 2018 Financial Results
November 05, 2018 16:00 ET
|
REVA Medical Inc
SAN DIEGO, Nov. 05, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today provided...
REVA Announces Commercial Launch of the Fantom Encore Bioresorbable Scaffold
October 31, 2018 19:19 ET
|
REVA Medical Inc
First Fantom Encore Implanted in the FANTOM Post Market Trial SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer...
REVA to Hold Third Quarter 2018 Financial Results Call
October 29, 2018 19:20 ET
|
REVA Medical Inc
SAN DIEGO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) has scheduled a conference call to review its third quarter 2018 financial results and provide a...
REVA Medical Presents Key Data Sets at the Transcatheter Cardiovascular Therapeutics Conference 2018
September 22, 2018 22:42 ET
|
REVA Medical Inc
SAN DIEGO, Sept. 22, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, presented four key...
New Data for Fantom in Heart Attack Patients to be Presented at the TCT 2018 Conference
August 16, 2018 00:05 ET
|
REVA Medical Inc
SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, will present new data...
REVA Medical Reports Second Quarter 2018 Financial Results
August 07, 2018 09:00 ET
|
REVA Medical Inc
SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today provided...
REVA to Hold Second Quarter 2018 Financial Results Call
July 31, 2018 19:04 ET
|
REVA Medical Inc
SAN DIEGO, July 31, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) has scheduled a conference call to review its second quarter 2018 financial results and provide a...
UPDATE: REVA Enters Peripheral Artery Disease Space With First-Ever CE Mark of a Bioresorbable Scaffold for Below the Knee Therapy
July 26, 2018 12:24 ET
|
REVA Medical Inc
SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced that...
REVA Enters Peripheral Artery Disease Space With First-Ever CE Mark of a Bioresorbale Scaffold for Below the Knee Therapy
July 25, 2018 19:15 ET
|
REVA Medical Inc
SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced that...
Reva Expands Commercial Access to Fantom With New Distribution Partnership in Italy
July 15, 2018 18:59 ET
|
REVA Medical Inc
SAN DIEGO, July 15, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, is expanding commercial...